ALIVUS
NSEAlivus Life Sciences Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,160.10
17.20 (1.50%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹14.24K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
24.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹819+41.6%
52W High₹1,193.9-2.8%
Current Price
₹1,160.10
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹928.08
Upper Circuit₹1,392.12
Reference Price
₹1,160.10
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1242.85
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1255.3
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 53.78 (BUY) with 86.4% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
86%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
1117.72
EMA50
1082.2
EMA200
1006.63
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹1148.40
₹1124.90
₹1096.05
₹1078.40
₹1024.03
Volume Analysis
TrendSTABLE
Change+0.80%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹1148.50
3% Risk₹1125.30
5% Risk₹1102.09
7% Risk (Custom)
₹1078.89Technical Levels
1x ATR (Volatility)₹1120.80
2x ATR (Swing)₹1081.50
3x ATR (Trend)₹1042.20
Immediate Support₹1148.40
Moving Averages
EMA 9 (Short-term)₹1140.61
EMA 20 (Medium-term)₹1117.72
EMA 50 (Trend)₹1082.20
EMA 200 (Long-term)₹1006.63
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹641.8 Cr | ₹602.5 Cr | ₹601.8 Cr | ₹672.9 Cr |
| Net Profit | ₹137 Cr | ₹141.9 Cr | ₹121.5 Cr | ₹150.3 Cr |
| EPS | ₹11.18 | — | ₹9.91 | ₹12.25 |
| Operating Profit | ₹200.8 Cr | ₹208.5 Cr | ₹181.3 Cr | ₹219.5 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Alivus Life Sciences Limited | ₹1,160.10 | +1.50% | 24.9 | ₹14.24K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 01 Sept 2025 | Dividend - Rs 5 Per Share | DIVIDEND |
| 17 Oct 2023 | Interim Dividend - Rs 22.50 Per Share | INTERIM_DIVIDEND |
| 22 Sept 2023 | Annual General Meeting | AGM |
| 24 Mar 2023 | Interim Dividend - Rs 21 Per Share | INTERIM_DIVIDEND |
| 15 Sept 2022 | Dividend - Rs 10.5 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ALIVUS
View All
positive
Business Standard - Markets 3d ago
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEACUTAASALIVUSBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYHIKALIOLCPJFLLIFEJFL-REJGCHEMLUPINMOMENTUMNIFTYQLITYORCHPHARMARPGLIFESAILIFESILVERSOLARASPARCSUVENTECHChemicalsFinancial Services
negative
LiveMint - Companies 3d ago
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its tissue of origin from a single blood sample.
ABGSECALIVUSJFLLIFEJFL-RERELIANCERELINFRARPGLIFESAILIFESUVENFinancial ServicesHealthcare
neutral
Google News - India Markets 8d ago
Market Trading Guide: Suven Life Sciences among 2 stock recommendations for Friday - The Economic Times
Market Trading Guide: Suven Life Sciences among 2 stock recommendations for FridayThe Economic Times
ALIVUSJFLLIFEJFL-RERPGLIFESAILIFESUVENHealthcare